Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929824 · ClinicalTrials.gov registry record
Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 50
- Enrollment target
NCT01929824: Completed study, sponsored by Mayo Clinic.
NCT01929824 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01929824 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).
Interventions
- OTHER Oral Nitric Oxide testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-08 |
| Est. Completion | 2019-09-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01929824
The ClinicalTrials.gov registry entry for NCT01929824 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Nitric Oxide testing is the first listed.
NCT01929824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01929824 about?
NCT01929824 is a clinical study titled "Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)". This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).
What is the current status of trial NCT01929824?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-08. Estimated completion is 2019-09-25.
What interventions are being tested in trial NCT01929824?
The interventions under investigation include: Oral Nitric Oxide testing (OTHER).
Who is sponsoring clinical trial NCT01929824?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.